Loading clinical trials...
Loading clinical trials...
In order to expand the treatment of Wilson disease and improve the quality of life of patients with Wilson's disease, the clinical effect of botulinum toxin type A injection on Wilson's disease was discussed.
Age
15 - 65 years
Sex
ALL
Healthy Volunteers
No
the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, #117 Meishan Street, Shushan District Hefei 230037, China
Hefei, China
Start Date
December 1, 2016
Primary Completion Date
December 1, 2023
Completion Date
January 1, 2024
Last Updated
January 15, 2025
60
ACTUAL participants
Botulinum toxin type A
DRUG
Lead Sponsor
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
NCT06573723
NCT07046507
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05047523